Literature DB >> 19211616

Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.

Lloyd Lecureux1, Matthew Z Dieter, David M Nelson, Linda Watson, Harvey Wong, Brian Gemzik, Curtis D Klaassen, Lois D Lehman-McKeeman.   

Abstract

The hepatobiliary disposition of thyroxine (T4) was evaluated in Groningen Yellow transport deficient (TR(-)) rats lacking functional multidrug resistance-associated protein 2 (Mrp2; Abcc2). Male Wistar and TR(-) rats were dosed orally (4 days) with phenobarbital (PB; 100 mg/kg) or DMP 904 (200 mg/kg), after which T4 homeostasis and hepatic cytochromes P450, UDP-glucuronosyltransferase, xenobiotic transporters, and T4 glucuronidation were determined. Serum concentrations of T4 were approximately 50% higher in control TR(-) rats than Wistars. PB and DMP 904 increased hepatic levels of P450s and T4-glucuronidation (T4-G), and these changes were associated with decreased serum T4 levels in both strains. In Wistar but not TR(-) rats, DMP 904 increased thyroid stimulating hormone levels twofold. Hepatobiliary clearance of T4 was determined after intravenous infusion of [(125)I]T4 to rats dosed with PB and DMP 904 (4 days). PB and DMP 904 increased plasma clearance and hepatic uptake of [(125)I]T4 equivalents in Wistar but not TR(-) rats. Total biliary clearance (Cl(bile)) was approximately 0.85 and 0.2 ml/h in Wistar and TR(-) rats, respectively, with virtually no T4-G excreted in bile in TR(-) rats. Biliary clearance of unconjugated T4 was also lower in control TR(-) rats than in Wistars, although DMP 904 increased its biliary clearance in both strains. These results suggest that Mrp2 is likely to be responsible for biliary excretion of T4-G and contributes in part to excretion of T4. Decreased biliary clearance of T4 and metabolites in TR(-) rats mitigated but did not prevent drug-induced changes in serum T4, suggesting that other factors contribute to changes in T4 homeostasis in these rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211616     DOI: 10.1093/toxsci/kfp026

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  7 in total

Review 1.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

2.  Polychlorinated biphenyl congeners that increase the glucuronidation and biliary excretion of thyroxine are distinct from the congeners that enhance the serum disappearance of thyroxine.

Authors:  L A Martin; D T Wilson; K R Reuhl; M A Gallo; C D Klaassen
Journal:  Drug Metab Dispos       Date:  2011-12-20       Impact factor: 3.922

3.  Role of UDP-glucuronosyltransferase (UGT) 2B2 in metabolism of triiodothyronine: effect of microsomal enzyme inducers in Sprague Dawley and UGT2B2-deficient Fischer 344 rats.

Authors:  Terrilyn A Richardson; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2010-04-26       Impact factor: 4.849

4.  Disruption of thyroid hormone homeostasis in Ugt1a-deficient Gunn rats by microsomal enzyme inducers is not due to enhanced thyroxine glucuronidation.

Authors:  Terrilyn A Richardson; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2010-07-22       Impact factor: 4.219

5.  Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.

Authors:  Wei Yue; Jin Kyung Lee; Koji Abe; Yuichi Sugiyama; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2010-11-24       Impact factor: 3.922

6.  Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in Young Long-Evans rats.

Authors:  Katie B Paul; Joan M Hedge; Michael J DeVito; Kevin M Crofton
Journal:  Toxicol Sci       Date:  2009-11-12       Impact factor: 4.849

7.  Hepatic Transporter Expression in Metabolic Syndrome: Phenotype, Serum Metabolic Hormones, and Transcription Factor Expression.

Authors:  Ajay C Donepudi; Qiuqiong Cheng; Zhenqiang James Lu; Nathan J Cherrington; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2016-02-04       Impact factor: 3.922

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.